An interventional study of Application Use in Diabetes Mellitus, Type 1, sponsored by University of California, Davis. Completed at 1 site in United States. Open to participants aged 1 Year to 17 Years. Per ClinicalTrials.gov, last updated 2021-04-20.
Sponsored by University of California, Davis · Not applicable, Interventional, and Health services research
To test the hypothesis that remote sharing of health data - including measured blood glucose values as well as patient-reported carbohydrate counts and insulin doses - with the UC Davis Pediatric Diabetes team via connected health applications is feasible for pediatric patients with newly diagnosed type 1 diabetes.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's enrollment of 41 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →University of California, Davis is the lead sponsor of 798 studies on the registry; 146 are open to participants now.
Of its 65 completed or terminated interventional studies of FDA-regulated products, 43 (66%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants will be asked to use applications to track food intake, carbohydrate counts, insulin delivered, and blood sugar values and share the data with the study team.
Behavioral: Application Use
The control group will receive usual care during their hospitalizations at the time of diabetes diagnosis, and during the time between hospital discharge and first visit to the UCD Pediatric Diabetes clinic.
Use applications after initial diagnosis to share information with study team.
Connected Health Survey
Parent reported survey to determine how often families review blood sugar numbers and the ease of use of the applications.
Time frame: 1 month after diabetes diagnosis
Connected Health Survey
Parent reported survey to determine how often families review blood sugar numbers and the ease of use of the applications.
Time frame: 6 months after diabetes diagnosis
Frequency of blood glucose monitoring
How often patients are monitoring their blood sugar (documented in electronic medical record)
Time frame: At each clinic visit until 6 months since diagnosis
Hemoglobin A1c values
Hemoglobin A1c values collected at each clinic visit (documented in electronic medical record)
Time frame: At each clinic visit until 6 months since diagnosis
Plan to share: No
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Davis